About

With over a decade of expertise in haematology and oncology across the UK and Germany, I bring unparalleled insight into clinical research, advanced therapies, and regulatory landscapes. My experience spans cutting-edge treatments for complex haematological malignancies, including leukaemia, lymphoma, myeloma, and myeloproliferative disorders, with specialised proficiency in stem cell transplantation, CAR-T cell therapy, gene therapy, and immunotherapy.

As a consultant based in the UK, I have honed my skills in designing and implementing personalised therapeutic strategies, managing advanced treatments like Graft versus Host Disease (GvHD), and delivering tailored conditioning regimens to optimise patient outcomes. My deep commitment to integrating the latest advancements in gene and immunotherapies keeps me at the forefront of innovative medical solutions.

My bilingual proficiency in English and German enables seamless collaboration with pharmaceutical companies and research teams across international settings, fostering effective communication and alignment in global projects. Having trained at the University of Cologne, Germany, with a PhD in haematology and stem cell transplantation, I possess a solid foundation in clinical practice and laboratory medicine, including Minimal Residual Disease (MRD) diagnostics.

During my tenure at leading institutions in Germany and the UK, I have actively contributed to clinical trials and collaborated with renowned research groups, such as the ALL-German group (GMALL). This experience equips me to provide pharmaceutical companies with strategic insights into clinical trial design, data analysis, and regulatory compliance, particularly within the European healthcare framework.

I am dedicated to partnering with pharmaceutical and biotech companies to advance innovative treatments, optimise clinical trials across phases I-III, and navigate the complexities of regulatory approval. My experience uniquely positions me to bridge the gap between clinical practice and drug development, delivering expert guidance to bring transformative therapies to market.

Let’s Collaborate
If your company seeks a trusted partner to drive haematology and oncology innovation, I invite you to explore how my expertise can support your goals.